[
    [
        {
            "time": "2021-11-15",
            "original_text": "Pfizer: The Pace of COVID-19 Vaccine Development Is Remarkable, Says Analyst",
            "features": {
                "keywords": [
                    "Pfizer",
                    "COVID-19",
                    "vaccine",
                    "development",
                    "analyst"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-11-15",
            "original_text": "Pfizer (PFE) Stock Moves -0.4%: What You Should Know",
            "features": {
                "keywords": [
                    "Pfizer",
                    "stock",
                    "moves",
                    "-0.4%"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-11-15",
            "original_text": "‘The most difficult phase of the epidemic is ahead of us’ : doctor",
            "features": {
                "keywords": [
                    "epidemic",
                    "difficult",
                    "phase",
                    "doctor"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 5,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-11-15",
            "original_text": "Bristol Myers Squibb, Exelixis Granted FDA Priority Review For Kidney Cancer Treatment",
            "features": {
                "keywords": [
                    "Bristol Myers Squibb",
                    "Exelixis",
                    "FDA",
                    "priority review",
                    "kidney cancer"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-15",
            "original_text": "Dow Jones Today, Stocks Rise On Stimulus Hope, China Data; Conoco To Buy Concho; Getting A Handle On Apple's Base",
            "features": {
                "keywords": [
                    "Dow Jones",
                    "stocks",
                    "rise",
                    "stimulus hope",
                    "China data",
                    "Conoco",
                    "Concho",
                    "Apple"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "technology",
                    "energy"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]